There has been an increase in observational studies using health administrative data to examine the nature, quality, and costs of care at life’s end, particularly in cancer care.
Aim:
To synthesize retrospective observational studies on resource utilization and/or costs at the end of life in cancer patients. We also examine the methods and outcomes of studies assessing the quality of end-of-life care.
Design:
A systematic review according to PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) and AMSTAR (A Measurement Tool to Assess Systematic Reviews) methodology.
Data sources:
We searched MEDLINE, Embase, CINAHL, and York Centre for Research and Dissemination (1990–2011). Independent reviewers screened abstracts of 14,424 articles, and 835 full-text manuscripts were further reviewed. Inclusion criteria were English-language; at least one resource utilization or cost outcome in adult cancer decedents with solid tumors; outcomes derived from health administrative data; and an exclusive end-of-life focus.
Results:
We reviewed 78 studies examining end-of-life care in over 3.7 million cancer decedents; 33 were published since 2008. We observed exponential increases in service use and costs as death approached; hospital services being the main cost driver. Palliative services were relatively underutilized and associated with lower expenditures than hospital-based care. The 15 studies using quality indicators demonstrated that up to 38% of patients receive chemotherapy or life-sustaining treatments in the last month of life and up to 66% do not receive hospice/palliative services.
Conclusion:
Observational studies using health administrative data have the potential to drive evidence-based palliative care practice and policy. Further development of quality care markers will enhance benchmarking activities across health care jurisdictions, providers, and patient populations.
DeVitaVTRosenbergSA. Two hundred years of cancer research. N Engl J Med2012; 366(23): 2207–2214.
2.
VogelzangNJBenowitzSIAdamsS. Clinical cancer advances 2011: annual report on progress against cancer from the American Society of Clinical Oncology. J Clin Oncol2012; 30(1): 88–109.
3.
SullivanRPeppercornJSikoraK. Delivering affordable cancer care in high-income countries. Lancet Oncol2011; 12(10): 933–980.
4.
YabroffKRWarrenJLBrownML. Costs of cancer care in the USA: a descriptive review. Nat Clin Pract Oncol2007; 4(11): 643–656.
5.
Boni-SaenzAADranoveDEmanuelLL. The price of palliative care: toward a complete accounting of costs and benefits. Clin Geriatr Med2005; 21(1): 147–163, ix.
6.
LubitzJCaiLKramarowE. Health, life expectancy, and health care spending among the elderly. N Engl J Med2003; 349(11): 1048–1055.
7.
LevineMNJulianJA. Registries that show efficacy: good, but not good enough. J Clin Oncol2008; 26(33): 5316–5319.
8.
EarleCCAyanianJZ. Looking back from death: the value of retrospective studies of end-of-life care. J Clin Oncol2006; 24(6): 838–840.
9.
WoithaKVan BeekKAhmedN. Development of a set of process and structure indicators for palliative care: the Europall project. BMC Health Serv Res2012; 12: 381.
10.
Worldwide Palliative Care Alliance and World Health Organization. Global atlas of palliative care at the end of life. Worldwide Palliative Care Alliance, www.who.int/nmh/Global_Atlas_of_Palliative_Care.pdf (2014, accessed 21 February 2014).
11.
EarleCCLandrumMBSouzaJM. Aggressiveness of cancer care near the end of life: is it a quality-of-care issue?J Clin Oncol2008; 26(23): 3860–3866.
12.
DonaldsonMSFieldMJ. Measuring quality of care at the end of life. Arch Intern Med1998; 158(2): 121–128.
13.
ZimmermannCRiechelmannRKrzyzanowskaM. Effectiveness of specialized palliative care: a systematic review. JAMA2008; 299(14): 1698–1709.
14.
De RooMLLeemansKClaessenSJ. Quality indicators for palliative care: update of a systematic review. J Pain Symptom Manage2013; 46(4): 556–572.
15.
HearnJHigginsonIJ. Do specialist palliative care teams improve outcomes for cancer patients? A systematic literature review. Palliat Med1998; 12(5): 317–332.
16.
PasmanHRBrandtHEDeliensL. Quality indicators for palliative care: a systematic review. J Pain Symptom Manage2009; 38(1): 145–156.
17.
Von ElmEAltmanDGEggerM. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol2008; 61(4): 344–349.
18.
Ngo-MetzgerQMcCarthyEPBurnsRB. Older Asian Americans and Pacific Islanders dying of cancer use hospice less frequently than older white patients. Am J Med2003; 115(1): 47–53.
19.
Ngo-MetzgerQPhillipsRSMcCarthyEP. Ethnic disparities in hospice use among Asian-American and Pacific Islander patients dying with cancer. J Am Geriatr Soc2008; 56(1): 139–144.
20.
SheffieldKMBoydCABenarroch-GampelJ. End-of-life care in Medicare beneficiaries dying with pancreatic cancer. Cancer2011; 117(21): 5003–5012.
21.
HoTHBarberaLSaskinR. Trends in the aggressiveness of end-of-life cancer care in the universal health care system of Ontario, Canada. J Clin Oncol2011; 29(12): 1587–1591.
22.
RosenwaxLKMcNamaraBA. Who receives specialist palliative care in Western Australia-and who misses out. Palliat Med2006; 20(4): 439–445.
23.
SheaBJHamelCWellsGA. AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews. J Clin Epidemiol2009; 62(10): 1013–1020.
24.
SheaBJGrimshawJMWellsGA. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol2007; 7: 10.
25.
LiberatiAAltmanDGTetzlaffJ. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ2009; 339: b2700.
26.
BergmanJSaigalCSLorenzKA. Hospice use and high-intensity care in men dying of prostate cancer. Arch Intern Med2011; 171(3): 204–210.
27.
AuDHUdrisEMFihnSD. Differences in health care utilization at the end of life among patients with chronic obstructive pulmonary disease and patients with lung cancer. Arch Intern Med2006; 166(3): 326–331.
28.
FassbenderKFainsingerRBrenneisC. Utilization and costs of the introduction of system-wide palliative care in Alberta, 1993–2000. Palliat Med2005; 19(7): 513–520.
29.
GielenBRemacleAMertensR. Patterns of health care use and expenditure during the last 6 months of life in Belgium: differences between age categories in cancer and non-cancer patients. Health Policy2010; 97(1): 53–61.
30.
GuestJFRuizFJGreenerMJ. Palliative care treatment patterns and associated costs of healthcare resource use for specific advanced cancer patients in the UK. Eur J Cancer Care2006; 15(1): 65–73.
31.
GuestJFRuizFJRussJ. A comparison of the resources used in advanced cancer care between two different strong opioids: an analysis of naturalistic practice in the UK. Curr Med Res Opin2005; 21(2): 271–280.
32.
LoJC. The impact of hospices on health care expenditures: the case of Taiwan. Soc Sci Med2002; 54(6): 981–991.
33.
LunneyJRLynnJHoganC. Profiles of older medicare decedents. J Am Geriatr Soc2002; 50(6): 1108–1112.
34.
Serra-PratMGalloPPicazaJM. Home palliative care as a cost-saving alternative: evidence from Catalonia. Palliat Med2001; 15(4): 271–278.
35.
ShugarmanLRBirdCESchusterCR. Age and gender differences in Medicare expenditures at the end of life for colorectal cancer decedents. J Womens Health2007; 16(2): 214–227.
36.
ShugarmanLRBirdCESchusterCR. Age and gender differences in medicare expenditures and service utilization at the end of life for lung cancer decedents. Womens Health Issues2008; 18(3): 199–209.
37.
AllanDEStajduharKIReidRC. The uses of provincial administrative health databases for research on palliative care: insights from British Columbia, Canada. BMC Palliat Care2005; 4: 2.
38.
BarberaLElitLKrzyzanowskaM. End of life care for women with gynecologic cancers. Gynecol Oncol2010; 118(2): 196–201.
39.
BarberaLSussmanJViolaR. Factors associated with end-of-life health service use in patients dying of cancer. Healthc Policy2010; 5(3): e125–e143.
40.
BurgeFILawsonBJohnstonG. Home visits by family physicians during the end-of-life: does patient income or residence play a role?BMC Palliat Care2005; 4(1): 1.
41.
DuffySACopelandLAHoppFP. Diagnostic classifications and resource utilization of decedents served by the Department of Veterans Affairs. J Palliat Med2007; 10(5): 1137–1145.
42.
GagnonBMayoNEHanleyJ. Pattern of care at the end of life: does age make a difference in what happens to women with breast cancer?J Clin Oncol2004; 22(17): 3458–3465.
43.
GoodridgeDLawsonJDugglebyW. Health care utilization of patients with chronic obstructive pulmonary disease and lung cancer in the last 12 months of life. Respir Med2008; 102(6): 885–891.
44.
GrandeGEMcKerralAToddCJ. Which cancer patients are referred to Hospital at Home for palliative care?Palliat Med2002; 16(2): 115–123.
45.
GrandeGEMcKerralAAddington-HallJM. Place of death and use of health services in the last year of life. J Palliat Care2003; 19(4): 263–270.
46.
SetoguchiSEarleCCGlynnR. Comparison of prospective and retrospective indicators of the quality of end-of-life cancer care. J Clin Oncol2008; 26(35): 5671–5678.
47.
O’BrienMBJohnstonGMGaoJ. End-of-life care for nursing home residents dying from cancer in Nova Scotia, Canada, 2000–2003. Support Care Cancer2007; 15(9): 1015–1021.
48.
BurgeFILawsonBJohnstonG. Health care restructuring and family physician care for those who died of cancer. BMC Fam Pract2005; 6(1): 1.
49.
AabomBKragstrupJVondelingH. Defining cancer patients as being in the terminal phase: who receives a formal diagnosis, and what are the effects?J Clin Oncol2005; 23(30): 7411–7416.
50.
CarlsonMDAHerrin DuQ. Impact of hospice disenrollment on health care use and medicare expenditures for patients with cancer. J Clin Oncol2010; 28(28): 4371–4375.
51.
CintronAHamelMBDavisRB. Hospitalization of hospice patients with cancer. J Palliat Med2003; 6(5): 757–768.
52.
EarleCCNevilleBALandrumMB. Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol2004; 22(2): 315–321.
53.
HuangJBoydCTyldesleyS. Time spent in hospital in the last six months of life in patients who died of cancer in Ontario. J Clin Oncol2002; 20(6): 1584–1592.
54.
LeglerABradleyEHCarlsonMDA. The effect of comorbidity burden on health care utilization for patients with cancer using hospice. J Palliat Med2011; 14(6): 751–756.
55.
LevinskyNGYuWAshA. Influence of age on Medicare expenditures and medical care in the last year of life. JAMA2001; 286(11): 1349–1355.
56.
LiuC-NYangM-C. National health insurance expenditure for adult beneficiaries in Taiwan in their last year of life. J Formos Med Assoc2002; 101(8): 552–559.
57.
LiuTWChenJSWangHM. Quality of end-of-life care between medical oncologists and other physician specialists for Taiwanese cancer decedents, 2001–2006. Oncologist2009; 14(12): 1232–1241.
58.
McNamaraBRosenwaxL. Specialist palliative care use for people dying of cancer in Western Australia. Cancer Forum2007; 31(1): 18–22.
59.
MiccinesiGCrocettiEMorinoP. Palliative home care reduces time spent in hospital wards: a population-based study in the Tuscany Region, Italy. Cancer Causes Control2003; 14(10): 971–977.
60.
MoorinREHolmanCDJ. The effects of socioeconomic status, accessibility to services and patient type on hospital use in Western Australia: a retrospective cohort study of patients with homogenous health status. BMC Health Serv Res2006; 6: 74.
61.
RosenwaxLKMcNamaraBAMurrayK. Hospital and emergency department use in the last year of life: a baseline for future modifications to end-of-life care. Med J Aust2011; 194(11): 570–573.
62.
SchneiderNDreierMAmelungVE. Hospital stay frequency and duration of patients with advanced cancer diseases - differences between the most frequent tumour diagnoses: a secondary data analysis. Eur J Cancer Care2007; 16(2): 172–177.
63.
SeowHPietLKenworthyCM. Evaluating a palliative care case management program for cancer patients: the Omega Life Program. J Palliat Med2008; 11(10): 1314–1318.
64.
SetoguchiSGlynnRJStedmanM. Hospice, opiates, and acute care service use among the elderly before death from heart failure or cancer. Am Heart J2010; 160(1): 139–144.
65.
TangSTWuSCHungYN. Trends in quality of end-of-life care for Taiwanese cancer patients who died in 2000–2006. Ann Oncol2009; 20(2): 343–348.
66.
WarrenJLBarberaLBremnerKE. End-of-life care for lung cancer patients in the United States and Ontario. J Natl Cancer Inst2011; 103(11): 853–862.
67.
BarberaLPaszatLChartierC. Indicators of poor quality end-of-life cancer care in Ontario. J Palliat Care2006; 22(1): 12–17.
68.
BarberaLPaszatLQiuF. End-of-life care in lung cancer patients in Ontario: aggressiveness of care in the population and a description of hospital admissions. J Pain Symptom Manage2008; 35(3): 267–274.
69.
KeatingNLLandrumMBLamontEB. End-of-life care for older cancer patients in the Veterans Health Administration versus the private sector. Cancer2010; 116(15): 3732–3739.
70.
SharmaGFreemanJZhangD. Trends in end-of-life ICU use among older adults with advanced lung cancer. Chest2008; 133(1): 72–78.
71.
SharmaGFreemanJZhangD. Continuity of care and intensive care unit use at the end of life. Arch Intern Med2009; 169(1): 81–86.
72.
WuS-CChenJ-SWangH-M. Determinants of ICU care in the last month of life for Taiwanese cancer decedents, 2001 to 2006. Chest2010; 138(5): 1071–1077.
73.
BarberaLTaylorCDudgeonD. Why do patients with cancer visit the emergency department near the end of life?CMAJ2010; 182(6): 563–568.
74.
BurgeFLawsonBJohnstonG. Family physician continuity of care and emergency department use in end-of-life cancer care. Med Care2003; 41(8): 992–1001.
75.
BergerADukesESmithM. Use of oral and transdermal opioids among patients with metastatic cancer during the last year of life. J Pain Symptom Manage2003; 26(2): 723–730.
76.
BergerASmithMLidskyL. Opioid use and health care charges at the end of life in patients with metastatic cancer. Manag Care Interface2004; 17(4): 28–34.
77.
GanziniLSochermanRDuckartJ. End-of-life care for veterans with schizophrenia and cancer. Psychiatr Serv2010; 61(7): 725–728.
78.
WalkerHAndersonMFarahatiF. Resource use and costs of end-of-Life/palliative care: Ontario adult cancer patients dying during 2002 and 2003. J Palliat Care2011; 27(2): 79–88.
79.
BurgeFILawsonBJJohnstonGM. A population-based study of age inequalities in access to palliative care among cancer patients. Med Care2008; 46(12): 1203–1211.
80.
EmanuelEJAshAYuW. Managed care, hospice use, site of death, and medical expenditures in the last year of life. Arch Intern Med2002; 162(15): 1722–1728.
81.
KeatingNLLandrumMBGuadagnoliE. Care in the months before death and hospice enrollment among older women with advanced breast cancer. J Gen Intern Med2008; 23(1): 11–18.
82.
McCarthyEPBurnsRBDavisRB. Barriers to hospice care among older patients dying with lung and colorectal cancer. J Clin Oncol2003; 21(4): 728–735.
83.
McCarthyEPBurnsRBNgo-MetzgerQ. Hospice use among medicare managed care and fee-for-service patients dying with cancer. JAMA2003; 289(17): 2238–2245.
84.
TangSTHuangEWLiuTW. Aggressive end-of-life care significantly influenced propensity for hospice enrollment within the last three days of life for Taiwanese cancer decedents. J Pain Symptom Manage2011; 41(1): 68–78.
85.
TangSTHuangEWLiuTW. A population-based study on the determinants of hospice utilization in the last year of life for Taiwanese cancer decedents, 2001–2006. Psychooncology2010; 19(11): 1213–1220.
86.
VirnigBAMarshall McBeanAKindS. Hospice use before death: variability across cancer diagnoses. Med Care2002; 40(1): 73–78.
87.
VirnigBAPersilyNAMorganRO. Do Medicare HMOs and Medicare FFS differ in their use of the Medicare hospice benefit?Hosp J1999; 14(1): 1–12.
88.
ChenJSWangHMWuSC. A population-based study on the prevalence and determinants of cardiopulmonary resuscitation in the last month of life for Taiwanese cancer decedents, 2001–2006. Resuscitation2009; 80(12): 1388–1393.
89.
JohnstonGMBoydCJJosephP. Variation in delivery of palliative radiotherapy to persons dying of cancer in Nova Scotia, 1994 to 1998. J Clin Oncol2001; 19(14): 3323–3332.
90.
LavergneMRJohnstonGMGaoJ. Variation in the use of palliative radiotherapy at end of life: examining demographic, clinical, health service, and geographic factors in a population-based study. Palliat Med2011; 25(2): 101–110.
91.
EmanuelEJYoung-XuYLevinskyNG. Chemotherapy use among Medicare beneficiaries at the end of life. Ann Intern Med2003; 138(8): 639–643 (Summary for patients in Ann Intern Med 2003 Apr 15; 138(8): I1, PMID: 12693915).
92.
CampbellDELynnJLouisTA. Medicare program expenditures associated with hospice use. Ann Intern Med2004; 140(4): 269–277.
93.
HanchateAKronmanACYoung-XuY. Racial and ethnic differences in end-of-life costs: why do minorities cost more than whites?Arch Intern Med2009; 169(5): 493–501.
94.
KardamanidisKLimKDa CunhaC. Hospital costs of older people in New South Wales in the last year of life. Med J Aust2007; 187(7): 383–386.
95.
KoroukianSMBeairdHMadiganE. End-of-life expenditures by Ohio Medicaid beneficiaries dying of cancer. Health Care Financ Rev2006; 28(2): 65–80.
96.
PolderJJBarendregtJJvan OersH. Health care costs in the last year of life: the Dutch experience. Soc Sci Med2006; 63(7): 1720–1731.
97.
PolednakAPShevchenkoIP. Hospital charges for terminal care of cancer patients dying before age 65. J Health Care Finance1998; 25(1): 26–34.
98.
PyensonBConnorSFitchK. Medicare cost in matched hospice and non-hospice cohorts. J Pain Symptom Manage2004; 28(3): 200–210.
99.
EarleCCParkERLaiB. Identifying potential indicators of the quality of end-of-life cancer care from administrative data. J Clin Oncol2003; 21(6): 1133–1138.
GrunfeldELethbridgeLDewarR. Towards using administrative databases to measure population-based indicators of quality of end-of-life care: testing the methodology. Palliat Med2006; 20(8): 769–777.
102.
GoodmanD. End-of-life cancer care in Ontario and the United States: quality by accident or quality by design?J Natl Cancer Inst2011; 103(11): 840–841.
103.
JenqGTinettiME. Changes in end-of-life care over the past decade: more not better. JAMA2013; 309(5): 489–490.
104.
ConnorSRTenoJSpenceC. Family evaluation of hospice care: results from voluntary submission of data via website. J Pain Symptom Manage2005; 30(1): 9–17.
105.
HoffmannTEruetiCThorningS. The scatter of research: cross sectional comparison of randomised trials and systematic reviews across specialties. BMJ2012; 344: e3223.
106.
VandenbrouckeJPVon ElmEAltmanDG. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Ann Intern Med2007; 147(8): W163–W194.
107.
TenoJMMorV. Resurrecting treatment histories of dead patients. JAMA2005; 293(13): 1591.
108.
BarnatoAELynnJ. Resurrecting treatment histories of dead patients. JAMA2005; 293(13): 1591–1592.
109.
BachPBSchragDBeggCB. Resurrecting treatment histories of dead patients: a study design that should be laid to rest. JAMA2004; 292(22): 2765–2770.
110.
YabroffKRMandelblattJSInghamJ. The quality of medical care at the end-of-life in the USA: existing barriers and examples of process and outcome measures. Palliat Med2004; 18(3): 202–216.
MackJWCroninATabackN. End-of-life care discussions among patients with advanced cancer: a cohort study. Ann Intern Med2012; 156(3): 204–210.
113.
MackJWWeeksJCWrightAA. End-of-life discussions, goal attainment, and distress at the end of life: predictors and outcomes of receipt of care consistent with preferences. J Clin Oncol2010; 28(7): 1203–1208.
114.
ZhangBWrightAAHuskampHA. Health care costs in the last week of life associations with end-of-life conversations. Arch Intern Med2009; 169(5): 480–488.
